FDA Inspection 1006248 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on March 9, 2017 in Greenville, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 9, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greenville, MS (United States)